Cassava Sciences, Inc.
Updated

Cassava Rockets After SEC Reportedly Clears It Of Tampering

403
SAVA:NASDAQ is one of those stocks that can get super spikey on news and after a 10 month investigation the SEC has apparently cleared them of any wrongdoing after having previously accused the company of manipulating research results of its experimental Alzheimers Disease drug.

Feels overbought at the moment looking at the RSI, but could be one to watch.
Note
Even the SEC couldn't save it. Headed down with the market. Still on the watch list.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.